Legal Representation
Attorney
Steven A. Abreu
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description |
|---|---|---|---|
| Nov 6, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Oct 5, 2021 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Oct 5, 2021 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Mar 16, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 16, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Mar 16, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 9, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 8, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 8, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 11, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Aug 11, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 11, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 6, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 4, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 12, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Biomedical compounds, namely, proteins, miniproteins, and cell-penetrating miniproteins (CPMPs) for use in scientific and laboratory research; biomedical compounds, namely, amino acids for laboratory or research use; biomedical compounds, namely, peptides, stapled peptides, and synthetic peptides, all comprised of amino acids, for use in scientific and laboratory research
Class 044
Providing information in the fields of health and medicine; providing medical information in the field of pharmaceutical and biopharmaceutical treatments
Additional Information
Pseudo Mark
TOWARD UNIVERSAL DRUG ABILITY
Classification
International Classes
001
044
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO